Schrödinger (SDGR) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Schrödinger Revenue Highlights

Latest Revenue (Y)

$216.67M

Latest Revenue (Q)

$47.33M

Main Segment (Y)

Drug Discovery Contribution

Main Geography (Y)

UNITED STATES

Schrödinger Revenue by Period

Schrödinger Revenue by Year

Date	Revenue	Change
2023-12-31	$216.67M	19.73%
2022-12-31	$180.96M	31.19%
2021-12-31	$137.93M	27.60%
2020-12-31	$108.09M	26.36%
2019-12-31	$85.54M	28.37%
2018-12-31	$66.64M	19.65%
2017-12-31	$55.69M	-

Schrödinger generated $216.67M in revenue during NA 2023, up 19.73% compared to the previous quarter, and up 325.13% compared to the same period a year ago.

Schrödinger Revenue by Quarter

Date	Revenue	Change
2024-06-30	$47.33M	29.33%
2024-03-31	$36.60M	-50.63%
2023-12-31	$74.13M	74.13%
2023-09-30	$42.57M	20.97%
2023-06-30	$35.19M	-45.68%
2023-03-31	$64.78M	13.97%
2022-12-31	$56.84M	53.71%
2022-09-30	$36.98M	-3.87%
2022-06-30	$38.47M	-20.95%
2022-03-31	$48.66M	5.40%
2021-12-31	$46.17M	54.67%
2021-09-30	$29.85M	0.22%
2021-06-30	$29.78M	-7.29%
2021-03-31	$32.13M	-2.74%
2020-12-31	$33.03M	28.05%
2020-09-30	$25.80M	11.71%
2020-06-30	$23.09M	-11.78%
2020-03-31	$26.17M	1.32%
2019-12-31	$25.83M	29.42%
2019-09-30	$19.96M	5.00%
2019-06-30	$19.01M	-8.35%
2019-03-31	$20.74M	18.68%
2018-12-31	$17.48M	34.51%
2018-09-30	$12.99M	-13.18%
2018-06-30	$14.96M	-17.25%
2018-03-31	$18.08M	-

Schrödinger generated $47.33M in revenue during Q2 2024, up 29.33% compared to the previous quarter, and up 73.07% compared to the same period a year ago.

Schrödinger Revenue Breakdown

Schrödinger Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 22	Dec 21	Dec 20
Drug Discovery Contribution	$1.95M	-	-
Software Contribution	-	$1.00M	-
Hosted Software	-	$11.08M	$9.19M
Software Products And Services	-	$113.24M	$92.53M
Revenue From Contract With Customer Before Software Contribution	-	$112.24M	-
Professional Services	-	$9.27M	$9.56M
On Premise Software	-	$74.60M	$58.31M
Maintenance	-	$17.29M	$14.46M
Revenue From Contract With Customer Before Contribution	-	-	$91.53M
Contribution	-	-	$1.00M

Schrödinger's latest annual revenue breakdown by segment (product or service), as of Dec 22: Drug Discovery Contribution (100.00%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Mar 24	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
Maintenance	$5.66M	$5.84M	$5.89M	$5.75M	$5.75M	$5.25M	$5.06M	$4.95M	$4.73M	$4.61M	$4.40M	$4.18M	$4.11M	$3.84M	$3.54M	$3.55M	$3.54M	-
Software Products And Services	$31.88M	$35.40M	$33.41M	$29.58M	$32.21M	$8.10M	$24.67M	$30.01M	$33.08M	$38.56M	$24.28M	$24.05M	$26.34M	$24.96M	$22.86M	$20.90M	$23.81M	-
On Premise Software	$12.25M	$18.76M	$17.62M	$13.81M	$19.94M	$33.63M	$12.58M	$16.59M	$21.69M	$27.30M	$15.50M	$14.45M	$17.36M	$16.54M	$15.06M	$11.11M	$15.60M	-
Professional Services	$2.04M	$2.72M	$2.73M	$2.08M	$2.07M	$4.81M	$3.11M	$3.87M	$3.41M	$3.57M	$1.70M	$1.72M	$2.28M	$2.20M	$1.89M	$2.93M	$2.54M	-
Revenue From Contract With Customer Before Contribution	$28.76M	$35.40M	$33.41M	$27.10M	$24.67M	$29.01M	$24.28M	$23.05M	$24.96M	$22.86M	$19.90M	-	-	-	-	-	-	-
Contribution	$3.12M	-	-	$1.80M	-	$1.00M	-	$1.00M	-	-	$1.00M	-	-	-	-	-	-	-
Hosted Software	$8.81M	$8.09M	$7.18M	$5.46M	$4.45M	$4.13M	$3.91M	$3.60M	$3.25M	$3.09M	$2.68M	$2.70M	$2.60M	$2.37M	$2.37M	$2.31M	$2.13M	-
Drug Discovery Contribution	-	-	-	-	$605.00K	-	-	-	-	-	-	-	-	-	-	-	-	-
Drug Discovery Services	-	-	-	-	-	$2.17M	$1.94M	$2.00M	$1.35M	-	-	-	-	-	-	-	-	-
Drug Discovery Services Revenue From Contracts With Customers	-	-	-	-	-	$31.80M	$11.72M	$8.02M	-	-	-	-	-	-	-	-	-	-
Drug Discovery	-	-	-	-	-	$32.57M	$10.04M	$12.31M	$8.46M	-	-	-	-	-	-	-	-	-

Schrödinger's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Software Products And Services (34.46%), Revenue From Contract With Customer Before Contribution (31.08%), On Premise Software (13.24%), Hosted Software (9.53%), Maintenance (6.11%), Contribution (3.38%), and Professional Services (2.20%).

Schrödinger Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 22	Dec 21	Dec 20
JAPAN	$10.47M	$8.56M	$14.56M
Non-US	$13.88M	-	-
UNITED STATES	$123.56M	$90.40M	$60.74M
Europe	$33.05M	$27.81M	$24.37M
Non Us	-	$11.16M	$8.43M

Schrödinger's latest annual revenue breakdown by geography, as of Dec 22: UNITED STATES (68.28%), Europe (18.26%), Non-US (7.67%), and JAPAN (5.79%).

Quarterly Revenue by Country

Country	Sep 24	Jun 24	Mar 24	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
Non-US	$243.00K	$121.00K	$604.00K	$117.00K	$156.00K	$3.43M	$3.65M	-	-	-	-	-	-	-	-	-	-
EMEA	$5.14M	$7.80M	$7.20M	$3.76M	$4.83M	-	-	-	-	-	-	-	-	-	-	-	-
APAC	$5.28M	$8.71M	$5.50M	$5.57M	$6.24M	-	-	-	-	-	-	-	-	-	-	-	-
UNITED STATES	$24.62M	$30.70M	$23.30M	$33.13M	$23.96M	$50.34M	$27.47M	$27.10M	$30.27M	$31.99M	$19.68M	$16.91M	$16.34M	$17.77M	$13.14M	$13.49M	-
JAPAN	-	-	-	-	-	$4.36M	$2.00M	$2.97M	$1.56M	$2.19M	$2.91M	$1.53M	$6.69M	$2.90M	$3.00M	$1.97M	-
Europe	-	-	-	-	-	$6.65M	$3.86M	$5.11M	$12.64M	$9.45M	$3.57M	$4.25M	$10.54M	$7.88M	$3.28M	$4.92M	$8.28M
Non Us	-	-	-	-	-	-	-	$3.29M	$4.19M	$2.53M	$2.54M	$2.95M	$3.14M	$2.12M	$1.85M	$2.03M	$2.44M
U S	-	-	-	-	-	-	-	-	-	-	$21.82M	-	-	-	-	-	-
J P	-	-	-	-	-	-	-	-	-	-	$1.92M	-	-	-	-	-	-

Schrödinger's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (69.77%), APAC (14.96%), EMEA (14.58%), and Non-US (0.69%).

Schrödinger Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
GEHC	GE HealthCare	$19.55B	$4.86B
TDOC	Teladoc Health	$2.60B	$640.51M
VEEV	Veeva Systems	$2.36B	$699.21M
PGNY	Progyny	$1.09B	$286.63M
HQY	HealthEquity	$999.59M	$300.43M
TXG	10x Genomics	$618.73M	$151.65M
DOCS	Doximity	$475.42M	$136.83M
ACCD	Accolade	$414.29M	$106.36M
CERT	Certara	$354.34M	$94.82M
SDGR	Schrödinger	$216.67M	$47.33M
AMWL	American Well	-	-

SDGR Revenue FAQ

What is Schrödinger’s yearly revenue?

Schrödinger's yearly revenue for 2023 was $216.67M, representing an increase of 19.73% compared to 2022. The company's yearly revenue for 2022 was $180.96M, representing an increase of 31.19% compared to 2021. SDGR's yearly revenue for 2021 was $137.93M, representing an increase of 27.60% compared to 2020.

What is Schrödinger’s quarterly revenue?

Schrödinger's quarterly revenue for Q2 2024 was $47.33M, a 29.33% increase from the previous quarter (Q1 2024), and a 34.51% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $36.6M, a -50.63% decrease from the previous quarter (Q4 2023), and a -43.51% decrease year-over-year (Q1 2023). SDGR's quarterly revenue for Q4 2023 was $74.13M, a 74.13% increase from the previous quarter (Q3 2023), and a 30.40% increase year-over-year (Q4 2022).

What is Schrödinger’s revenue growth rate?

Schrödinger's revenue growth rate for the last 3 years (2021-2023) was 57.08%, and for the last 5 years (2019-2023) was 153.28%.

What are Schrödinger’s revenue streams?

Schrödinger's revenue streams in c 22 are Drug Discovery Contribution

What is Schrödinger’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of Schrödinger was Drug Discovery Contribution. This segment made a revenue of $1.95M, representing 100.00% of the company's total revenue.